Partners

Cizzle is involved in a number of academic and commercial partnerships that are designed to extend data sets, generate tools and materials and expand the knowledge base from which Cizzle conducts its operations.

During 2011, Cizzle plans to enter into more arrangements with commercial organisations which will bring forward development plans for the diagnostic and biomarker potential for Ciz1 in lung cancer. 

If you are interested in knowing more about partnering opportunities, please contact: john.lucas@cizzlebiotech.co.uk

Investors

Lead investors in Cizzle are the White Rose Technology Seedcorn Fund (WRTSCF), Yorkshire Cancer Research and The Viking Fund.

Cizzle Biotech
Heslington Hall, Heslington, York, North Yorkshire, Y010 5DD
UK company 5249093